Literature DB >> 1183254

Brain tumors of early infants.

O Sato, A Tamura, K Sano.   

Abstract

The authors describe their experience with ten cases of brain tumors in children in whom the onset of symptoms occurred within the first year of life, but who were operated on when they were 2 months to 4 years of age. The series includes 5 gliomas (4 supratentorial, 1 cerebellar; 3 astrocytomas, 1 spongioblastoma, 1 ependymoblastoma), 2 teratomas of the lateral ventricle, and 3 single cases of third ventricle choroid plexus papilloma, temporal lobe sarcoma, and a parasellar craniopharyngioma. Six cases were partially removed, one of them was shunted. Only biopsy was carried out in two, one of which was shunted. The only case of radical removal was a lateral ventricle teratoma; this patient died at operation. Nine patients survived at surgery, three of whom are alive on the 3rd, 4th, and 7th postoperative year. There were two late deaths: one at 2 years (lateral ventricle astrocytoma, which was only biopsied) and one at 7 years and 3 months (spongioblastoma) following surgery. This series from a 40-year period (1933-1973) represents 0.4% of 2,832 brain tumors and 1.9% of 528 brain tumors in the pediatric age. The authors emphasize the need to treat brain tumors in early infancy and insist on the use of radiotherapy and chemotherapy when the lesions are not radically removed at surgery.

Entities:  

Mesh:

Year:  1975        PMID: 1183254     DOI: 10.1159/000119560

Source DB:  PubMed          Journal:  Childs Brain        ISSN: 0302-2803


  16 in total

1.  Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.

Authors:  Anthony P Y Liu; Camden Hastings; Shengjie Wu; Johnnie K Bass; Andrew M Heitzer; Jason Ashford; Robert Vestal; Mary E Hoehn; Yahya Ghazwani; Sahaja Acharya; Heather M Conklin; Frederick Boop; Thomas E Merchant; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

2.  Report of a case of congenital glioblastoma multiforme: an immunohistochemical study.

Authors:  D Mazzone; G Magro; A Lucenti; S Grasso
Journal:  Childs Nerv Syst       Date:  1995-05       Impact factor: 1.475

3.  Intracranial tumours in the first 18 months of life.

Authors:  R Kumar; I H Tekkök; R A Jones
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 4.  Surgical treatment of brain tumors in infants younger than six months of age and review of the literature.

Authors:  Shih-Shan Lang; Lauren A Beslow; Brandon Gabel; Alex R Judkins; Michael J Fisher; Leslie N Sutton; Phillip B Storm; Gregory G Heuer
Journal:  World Neurosurg       Date:  2011-11-07       Impact factor: 2.104

5.  Has modern management improved the outcome of infants with intracranial tumors?

Authors:  R Kumar; R A Jones; I H Tekkök
Journal:  Childs Nerv Syst       Date:  1990-09       Impact factor: 1.475

6.  Brain tumors with symptomatic onset in the first two years of life.

Authors:  M R Balestrini; R Micheli; L Giordano; G Lasio; S Giombini
Journal:  Childs Nerv Syst       Date:  1994-03       Impact factor: 1.475

7.  Congenital brain tumors in Japan (ISPN Cooperative Study): specific clinical features in neonates.

Authors:  S Oi; T Kokunai; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1990-03       Impact factor: 1.475

8.  Supratentorial tumours in infants.

Authors:  M K Tewari; B S Sharma; R K Mahajan; V K Khosla; S N Mathuriya; A Pathak; V K Kak
Journal:  Childs Nerv Syst       Date:  1994-04       Impact factor: 1.475

9.  Intracranial tumours in the first year of life. A report on 51 cases.

Authors:  C Di Rocco; A Ceddia; A Iannelli
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 10.  Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.

Authors:  P K Duffner; J P Krischer; P C Burger; M E Cohen; J W Backstrom; M E Horowitz; R A Sanford; H S Friedman; L E Kun
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.